The Impact of Vaginal Washing on Cervical Inflammation
NCT06615232 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 122
Last updated 2026-05-05
Summary
Vaginal washing is a common practice that many women perceive as hygienic. However, vaginal washing has been linked to adverse reproductive health outcomes including increased HIV acquisition risk. The mechanism linking vaginal washing to HIV risk remains unknown, but may be related to increased inflammation caused by intravaginal washing practices. The primary objective of this study is to test the hypothesis that a vaginal washing cessation intervention will reduce concentrations of soluble inflammatory mediators in cervicovaginal fluid and total immune cells in mucosal tissue, reduce cervical epithelial disruption, and increase concentrations of protective vaginal Lactobacillus spp. compared to control.
Conditions
- Reproductive Behavior
Interventions
- BEHAVIORAL
-
Vaginal washing cessation
Participants will attend weekly small group (\~10 women per group) sessions that are structured using the transtheoretical model of behavioral change to promote vaginal washing cessation.
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH -
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
collaborator NIH - lead OTHER
Principal Investigators
-
Michelle Sabo, Md, PhD · University of Washington
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-05-16
- Primary Completion
- 2026-10-31
- Completion
- 2029-06-30
Countries
- Kenya
Study Locations
More Related Trials
-
Prospective Evaluation of Infectious Vulvovaginitis on Wound Complication Rates After Vulvar Excision for Premalignant Lesions
NCT06070454 ·Status: RECRUITING ·Phase: NA
-
Effects of Contraceptive Ring on Vaginal Microbiota, HIV Shedding and Local Immunity
NCT02445989 ·Status: COMPLETED ·Phase: PHASE4
-
A Single-Center, Clinical Study to Evaluate the Safety of a Non-Fragranced Personal Lubricant in Healthy Female Subjects
NCT02320227 ·Status: COMPLETED ·Phase: NA
-
Optical Imaging and User Perception Study of Vaginal Gel
NCT01716000 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Pharmacokinetics of Dapivirine (TMC120) Vaginal Microbicide Gel
NCT00304642 ·Status: COMPLETED ·Phase: PHASE1
-
Accuracy and Acceptability of Self-Diagnostic Methods for Vaginitis in Adolescent Females
NCT00706368 ·Status: UNKNOWN ·Phase: NA
-
Vaginal Inflammation Markers in Postmenopausal Women With and Without Symptoms of Vaginal Inflammation
NCT01899612 ·Status: COMPLETED
-
Safety and Efficacy of Vaginal Microbiota Transplant (VMT) in Women With Bacterial Vaginosis (BV)
NCT03769688 ·Status: WITHDRAWN ·Phase: PHASE1
-
Chlorhexidine vs. Iodine for Vaginal Preparation in Urogynecologic Procedures
NCT04048356 ·Status: COMPLETED ·Phase: PHASE3
-
Integrated Genetic and Functional Analysis of the Influence of Menstrual Hygiene Products on Female Health
NCT06519799 ·Status: RECRUITING ·Phase: NA
-
A Single Group Study to Evaluate the Effects of a pH Balanced Cleanser on Women's Intimate Health.
NCT06516731 ·Status: COMPLETED ·Phase: NA
-
A Study of BufferGel in Women
NCT00000927 ·Status: COMPLETED ·Phase: PHASE1
-
Multi-Center Study of New Medications to Treat Vaginal Infections
NCT02308033 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Internal Menstrual Protections on Immunity and Vaginal Microbiota
NCT07199998 ·Status: RECRUITING
-
Interventional Study of Mucosal and Antimicrobial Responses to Repeated Vaginal Applications of Tenofovir Gel in HIV Uninfected Women
NCT00594373 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in South Africa
NCT00304668 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Safety and Acceptability of SPL7013 Gel (VivaGel™) in Sexually Active Women
NCT00442910 ·Status: COMPLETED ·Phase: PHASE1
-
Multi-Center Study of New Medications to Treat Vaginal Infections
NCT02308046 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of VagiVitalAC for Treatment of Candida Vulvovaginitis
NCT05012852 ·Status: UNKNOWN ·Phase: NA
-
A Study of Nonoxynol-9 (N-9) and HIV Infection
NCT00000926 ·Status: COMPLETED ·Phase: PHASE3
-
Multi-Center Study of New Medications to Treat Vaginal Infections
NCT02308007 ·Status: COMPLETED ·Phase: PHASE3
-
Relation Between Internal Vaginal Douching and Vaginal Infections in Intrauterine Contraceptive Device Users
NCT03261804 ·Status: COMPLETED
-
Once Daily In-situ Forming Versus Twice-daily Conventional Metronidazole Vaginal Gels for Treatment of Bacterial Vaginosis
NCT02365389 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Safety and Tolerability Study of Dapivirine (TMC120) Vaginal Microbicide Gel
NCT00303576 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Trial of SAVVY Vaginal Gel and HIV in Nigeria
NCT00130078 ·Status: UNKNOWN ·Phase: PHASE3